Pfizer Triples Down On CDK Inhibition In Breast, Other Cancers

CDK2, CDK4, CDK2/4/6 Drugs Now In Early Trials

 
• By Mandy Jackson
Digital 3d illustration of cancer cells in human body
Pfizer looks to strengthen its breast cancer position with additional CDK inhibitors • Source: Shutterstock

More from Anticancer

More from Therapeutic Category